Companies / bluebird bio, Inc.
bluebird bio, Inc.
BLUECIK 1293971
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 4, 2021 | Leschly Nick CEO | Exercise Option exercise | Common Stock | $1.12M | +203K +195.11% | 307,580 | low |
| Jan 2, 2015 | Finer Mitchell H. Executive | Sell Open-market sale | Common Stock | $825.4K | -9K -31.18% | 20,645 | medium |
| Jun 1, 2021 | Klima Thomas J Executive | Grant Grant or award | Common Stock | $777.8K | +25K | 25,000 | low |
| Jan 2, 2015 | Finer Mitchell H. Executive | Sell Open-market sale | Common Stock | $690.2K | -8K -91.76% | 674 | medium |
| Mar 10, 2015 | Walsh Jeffrey T. Executive | Sell Open-market sale | Common Stock | $681.4K | -6K -59.20% | 4,284 | medium |
| Feb 10, 2015 | Walsh Jeffrey T. Executive | Sell Open-market sale | Common Stock | $640.9K | -8K -71.66% | 2,976 | medium |
| Jan 2, 2015 | Finer Mitchell H. Executive | Sell Open-market sale | Common Stock | $619.3K | -7K -40.18% | 10,225 | medium |
| Jan 12, 2015 | Walsh Jeffrey T. Executive | Sell Open-market sale | Common Stock | $584.6K | -6K -100.00% | 0 | medium |